News Room

New report: Biopharmaceutical industry supports over 4 million jobs and $1.1 trillion in U.S. economic output

February 13, 2020

A new report from TEConomy Partners found that the biopharmaceutical industry supports over four million U.S. jobs and over $1.1 trillion in economic output. The biopharmaceutical

Almost Half of Spending on Brand Medicines Goes to PBMs, the Supply Chain, Other Entities – Not to Drug Companies

January 29, 2020

$166 billion in discounts intended for patients goes to middlemen New Brunswick, Jan. 29, 2020 ― An important new study sheds light on the dynamics

We can lower health care costs and keep N.J.’s pharmaceutical industry hard at work at the same time (NJ.com)

January 27, 2020

Although New Jersey’s biopharmaceutical sector opposed H.R. 3, we share its overriding goal – to ensure that patients can access the treatments and cures that

CEOs of four HINJ-member companies, HINJ President & CEO named to NJBIZ Manufacturing Power 50

January 2, 2020

From NJBIZ: The history of manufacturing in New Jersey is the history of manufacturing in America. Historians can trace the birth of the country’s political

HINJ Statement on the Medical Device Excise Tax Repeal

December 18, 2019

HINJ President and Chief Executive Officer Dean J. Paranicas has issued the following statement about the full repeal of the medical device excise tax: “Patients,

HINJ Honors Pioneering Genetics Researcher Jay Tischfield of Rutgers

December 9, 2019

HINJ honored Prof. Jay A. Tischfield of Rutgers University–New Brunswick today (Dec. 9, 2019) “in recognition of innovative and creative leadership in genetics research, scholarship